The antibody titers were determined 81.9 % in the dyspeptic-patient group and 35.7 % in normal control (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Helicobacter pylori (HP) is known to be a microorganism which is associated with gastritis and peptic ulcer disease. 72 patients with dyspepsia and 56 healthy individuals were tested for detection of the HP Immunoglobulin G (IgG) which was previously showed to be a usalde method for detection of the patients and controlled for treatment efficacy, and titers of them in the sera samples by HP IgG-lmmunoComb Enzyme Immunoassay (EIA) test kits.
📊
Key Findings & Data:Helicobacter pylori (HP) is known to be a microorganism which is associated with gastritis and peptic ulcer disease. 72 patients with dyspepsia and 56 healthy individuals were tested for detection of the HP Immunoglobulin G (IgG) which was previously showed to be a usalde method for detection of the patients and controlled for treatment efficacy, and titers of them in the sera samples by HP IgG-lmmunoComb Enzyme Immunoassay (EIA) test kits.
💡
Conclusion & Impact:The antibody titers were determined 81.9 % in the dyspeptic-patient group and 35.7 % in normal control (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Helicobacter pylori (HP) is known to be a microorganism which is associated with gastritis and peptic ulcer disease. 72 patients with dyspepsia and 56 healthy individuals were tested for detection of the HP Immunoglobulin G (IgG) which was previously showed to be a usalde method for detection of the patients and controlled for treatment efficacy, and titers of them in the sera samples by HP IgG-lmmunoComb Enzyme Immunoassay (EIA) test kits. The antibody titers were determined 81.9 % in the dyspeptic-patient group and 35.7 % in normal control (p
Özet
Helicobacter pylori (HP), gastrit ve peptik ülser ile ilişkili olduğu bilinen bir mikroorganizmadır. Olguların be¬lirlenmesinde ve tedavi etkinliğinin araştırılmasında kullanılabilirliği gösterilmiş olan HP Immunoglobulin G (IgG)nin dispeptik hastalardaki sıklığını belirlemek amacı ile 72 kişiden oluşan dispeptik yakınmalı hastadan ve 56 kişilik kon¬trol grubundan alınan serum örneklerinde HP IgG ImmunoComb Enzyme Immunoassay (EIA) test kitleri kullanılarak antikor pozitiflikleri ve titreleri araştırıldı. Dispeptik hastalarda antikor pozitifliği % 81.9, kontrol grubunda ise % 35.7 bulundu (p
🔖
Cite This Article
GÖRENEK, L., HACIBEKTAŞOĞLU, A., DİZER, U., ŞENGÜL, A., ÖZGÜVEN, V. (2022). Helicobacter pylori IgG prevalence in dyspeptic patients. Türk Hijyen ve Deneysel Biyoloji Dergisi, Cilt: 53 - Sayı: 1, 7–10. https://ajindex.com/articles/625319
Clearfield H.R. Helicobacter pylori: Agressor or innocent bystander ?. Med. Clin. N. Ame. 75; 815-828, 1991
Miller J.P., Faragher E.B. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease. Scand. J. Gastroenterol. 24; 39-45, 1989
Goodwin C.S., Bilincow E., Peterson G., etal. Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in gastric mucosa. J. infectio. Dis. 155; 488-494, 1987
Kaldor J., Tee W., Mc Carthy P., etal. immune response to Campylobacter pyloridis in patients with peptic ulcera- tion (Letter). Lancet i; 921, 1985
Morris A. Nicholson G., Lloyd G. Seroepidemiyoloji of Campyiobacter pyloridis, N. Zealand Med. J. 99; 657-659, 1986
Vaira D., Holton J., Cairns S.R., etal. Antibody titers to Campylobacter pylori after treatment for gastritis. Bri. Med. J. 297; 397, 1988. 7- von Wulffen H., Grote H.J. Enzyme linked immunosorbent assay for detection of immunoglobulin A and G anti- bodies to Campiobacter pylori. Eur. J. CM. Microbiol. Infect. Dis. 7; 559-565, 1988. 8- von Wulffen H., Grote H.J., Gatermann S., etas. Immunoblot analysis of immune response to Campylobacter pylori and its clinical associations. J. Clin. Pathol. 41; 653-659, 1988_ 9- Perez-Perez al., Dworkin B.M., Chodos J.E., etal Carnpylobacter pylori antibodies in human. Ann. ir:t. Med. i09; 11-17, 1988. 10, Rauws E.A.J. Detecting Campylobacter pylori with the 12C- an t4C-urea breath test. Scand. J. Gastroenterol. 24; 25-26, 1989
Graham D.Y, Campylobacter pylori as a pathogenetic factor in duodenal ulcer: the case for. Scurid. J. Gastroen, terol. 24; 45-52, 1989
Hoveluis B., Anderson S.i,, Hagender B., etal. Dyspepsia in general practice: History and symptoms in rotation to Helicobacter pylori sE::ur r. antibodies. Scand. J. Gastroenterol. 29; 506-510, 1994
Megraud F., Brassens-Rabee M.P., Denis F., etal. Seroepidemiology of Campylobacter pylori infection in various population. J. Clin. Microbiol. 27; 1870-1873, 1989
Aydin F., KOseahmet F., KatircioOlu I. ye ark. Antral kronik gastritte Helicobacter pylori (H.pylori) varliginin gas- terilmesinde Gram boyama, kultur ve serolojik yontemlerin karTlaprilmasi, Turk Mikrobiyol. Cern. Derg. 23; 231-233, 1993
Evans D.J., Evans D G,, Graham ON, etal. A sensitive and specific serologic test for detection of Campylobac- ter pylori infection. Gastroenterol. 96; 1004-1008, 1989.